Dr. rer. nat. Tobias Buchborn
+49 621 1703-6245
Institute for Psychopharmacology
CIMH (IZN, Univ. Heidelberg)
Affl.: Imperial College London
Department of Brain Sciences
Who I am
I am a German psychologist and neurobiologist and I do neuropharmacological research on serotonergic hallucinogens (aka psychedelics or entheogens).
If you are interested in how I found my way into psychedelic research, feel invited to have a read through a recent interview I gave to the Amsterdam Psychedelic Research Association (APRA).
I graduated in Psychology (Pre-Dipl. and Dipl.) at the Otto-von-Guericke University (OvGU) in Magdeburg, Germany, and within my Diploma thesis investigated the antidepressant-like properties of LSD in an animal model of depression.
I received my PhD (Dr. rer. nat.) in Neurobiology from the Faculty of Natural Sciences, OvGU, based on research at the Institute of Pharmacology and Toxicology with primary supervision by Prof. Dr. med. Volker Höllt. My PhD project addressed the behavioural and molecular biological correlates of tolerance to the serotonergic hallucinogens LSD, DMT, and DOB with focus on processes of 5-HT2A receptor regulation.
In 2016, I was awarded an Individual Marie Curie Research Fellow and joined the Laboratory for Neuronal Circuit Dynamics (LNCD) at Imperial College London. In collaboration with the Beckley/Imperial Psychedelic Research Programme, I here used refined methods of optogenetic neurophysiology to illuminate the relevance of cortical pyramidal cells and peripyramidal haemodynamics for the mechanism of action of serotonergic hallucinogens.
Currently, I am with the Lab for Translational Psychopharmacology (Central Institute of Mental Health Mannheim, Univ. Heidelberg), where we investigate the therapeutic applicability of Psilocybin in animal models of alcohol addiction.